Teva Pharmaceutical Industries Limited (TEVA) Discusses on Olanzapine LAI (TEV-‘749)
Christopher Stevo - Senior Vice President of Investor Relations & Competitive Intelligence Eric Hughes - Executive VP of Global R&D and Chief Medical Officer Christine Fox - Executive VP of U.S. Commercial BusinessPresentation Operator Welcome to the Olanzapine LAI TEV-'749 Phase III SOLARIS Data Presentation Conference Call. My name is Elliot, and I'll be coordinating your call today. [Operator Instructions]. I would now like to hand over to Christopher Stevo. Please go ahead. Christopher StevoSenior V ...